Aligos Therapeutics (ALGS) Assets (2019 - 2026)
Aligos Therapeutics (ALGS) posted Assets of $66.33 million for Q2 2026, down 50.8% from $134.71 million a year earlier but up 2.7% from the prior quarter.
Aligos Therapeutics (ALGS) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics' Assets came in at $88.53 million, up 26.3% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Assets was $70.09 million in FY2024 (-53.7%), $151.53 million in FY2023 (+3.3%), $146.69 million in FY2022 (-37.7%) and $235.37 million in FY2021 (-11.3%).
- Quarterly Assets has run from a low of $64.56 million in Q1 2026 to a high of $263.07 million in Q3 2021 over five years.
- On a year-over-year basis, Assets increased in five of the last eight quarters, with an average decline of 8.3%.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2021, with growth of 185.4%; the weakest was Q1 2026, with a decline of 57.2%.
- According to Business Quant data, Assets for the three prior quarters was $64.56 million (Q1 2026), $88.53 million (Q4 2025) and $109.76 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.06 Bn | 1,096.64 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.47 Bn | 534.00 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.80 Bn | 477.91 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 368.45 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.44 Bn | 262.43 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.92 Bn | 235.60 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.10 Bn | 191.50 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.91 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Aligos Therapeutics | 53.61 Mn | -274.79 Mn | - | 66.33 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.33 Mn |
| Mar 31, 2026 | 64.56 Mn |
| Dec 31, 2025 | 88.53 Mn |
| Sep 30, 2025 | 109.76 Mn |
| Jun 30, 2025 | 134.71 Mn |
| Mar 31, 2025 | 150.70 Mn |
| Dec 31, 2024 | 70.09 Mn |
| Sep 30, 2024 | 88.43 Mn |
| Jun 30, 2024 | 108.81 Mn |
| Mar 31, 2024 | 127.90 Mn |
| Dec 31, 2023 | 151.53 Mn |
| Sep 30, 2023 | 85.85 Mn |
| Jun 30, 2023 | 106.13 Mn |
| Mar 31, 2023 | 121.74 Mn |
| Dec 31, 2022 | 146.69 Mn |
| Sep 30, 2022 | 164.07 Mn |
| Jun 30, 2022 | 182.52 Mn |
| Mar 31, 2022 | 210.47 Mn |
| Dec 31, 2021 | 235.37 Mn |
| Sep 30, 2021 | 263.07 Mn |
Aligos Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();